Navigation Links
Low Cost Tissue Culture Vaccine For Encephalitis

The Indian Ministry of Health is in search of a new cheaper tissue culture vaccine for Japanese encephalitis. So far the Gorakhpur Government has reported 200 deaths and 700 patients with infection. // Hundreds of people are infected and die every year due to the endemic infection of Encephalitis in Uttar Pradesh. This year the death toll touched 228 in Gorakhpur, with 67 patients were admitted in the Government College Hospital in the last 24 hours, in which 12 persons died.

The health ministry is looking out for cheaper tissue culture encephalitis vaccine, which is produced by China and Korea which is an alternative to expensive mouse brain vaccine, which is produced by Central Research Institute, (CRI) in India. ‘‘The Drug Controller General of India is taking a view on the matter. The permission can be granted only after analyzing the safety and efficacy data supplied by the countries,’’ said Dr Anbumani Ramadoss, Union Minister of Health and Family Welfare. According to the Health ministry, the CRI has increased the production of vaccine from 5 lakhs units to 10 lakhs this year. The vaccine requires 3 doses of primary immunization, in which two doses are administered in between 7 to 14 days. The third dose is given after a month and before one year of the second dose. The vaccine requires booster dosage every three years. ‘‘We don’t want to say the areas are endemic and then forget about them. We will make sure the outbreak doesn’t happen next year,’’ the Minister added.

The result from the National Vector Borne Disease Control Program reports the annual incidence of 1765 to 3428 cases every year. The report from the study shows that every year 466 to 707 patients die. During 2003, more than 1000 children’s died of Japanese Encephalitis. In the past 10 years, the disease has spread to 15 States.

'"/>




Page: 1

Related medicine news :

1. Free Tissue Transfer Effective in Treating Massive Skin Cancers
2. Tissue Transfer for Skin Cancer
3. Tissue Transfer For Treatment Of Massive Skin Cancers
4. Loss Of Brain Tissue Linked To Obesity
5. Adult Stem Cells From Fat Tissues For Healing
6. Stem cell therapy for developing new trachea using Tissue engineering
7. A Novel Method For Measuring Interstitial Fluid Pressure In Cancer Tissues
8. Three In One Ultrasound Probe For 3-D Imaging Of Heart And Tissue Destruction Developed
9. Bisphenol A In Food Containers Has Adverse Effect On Brain Tissue
10. Lack Of Estrogen In Brain Tissue Of Women Can Lead To Alzheimers
11. Synthetic Bone Tissue Could Be the Answer to Disfigurement Caused by Oral Cancer
Post Your Comments:
(Date:7/25/2008)... This donation will be used to facilitate...ices for children , Haupp...ivci.com ), a leading integrator of enterprise co...deo conferencing, telepresence, audio visual integ...ed today that it has donated video conferencing eq...
(Date:7/24/2008)...EM, N.C. Researchers at Wake Forest University B...ng clinical belief that the hepatitis C virus slow... itself after HIV patients are treated with a comb...atitis C (HCV) infection is more serious in HIV-in...rding to the Centers for Disease Control. Intraven...
(Date:7/24/2008)...July 24 /PRNewswire-USNewswire/ -- Speaker Nancy P...g in support of the Tom Lantos,and Henry J. Hyde G...nd,Malaria Reauthorization Act of 2008. The bill, ...e this evening by a vote of 303 to 115 and will no...Today the House took an historic vote to pass land...
(Date:7/24/2008)...olo., July 24 /PRNewswire/ -- An Arapahoe County D...ic company what will likely,amount to more than $1...tween the minority shareholders of Inverness-based...-based private company PR Pharmaceuticals, Inc.,Th...dent, Steven Howe, and,CEO, Dr. Patrick Bols, brea...
Breaking Medicine News(10 mins):Health News:Mt. Sinai's Children's Trauma Institute Treatment and Service Adaptation Center Receives Video Conferencing Donation From IVCi 2Health News:Researchers disprove long-standing belief about HIV treatment 2Health News:Researchers disprove long-standing belief about HIV treatment 3Health News:Pelosi Statement on House Passage of Global AIDS Legislation 2Health News:Jury Award to Englewood Company to Total More Than $1 Million for Breach of Fiduciary Duties in Shareholder Class Action Case 2
... fish at least once a month can minimise the risk ...d researchers. Around 607 participants developed...dy involving more than 43,005 men aged 39 to 76. I...clot that blocks the blood vessel supplying the br...
...ug fluvoxamine has been found by researchers to be...od shifts in women with borderline personality dis...renic, non-bipolar women with borderline// persona...onducted by researchers from various universities ...
...evious research evidence that HRT could reduce ris...n reversed by a recent study of 1000 women of ages...r in the United Kingdom.The aim of the study was t...and progesterone reduced the risk of future heart ...
...chers in there study are trying to observe why su...e but studies are ongoing. It's long been known th...and other mental functions after an operation// - ...function (POCD).Often relatives will say that the ...
Other Medicine News:
(Date:7/22/2008)...July 22 /- Following a,thor...rd of Progen,Pharmaceuticals Limited (ASX: PGL; Na...ed the PI-88 phase 3 study in liver cancer. Progen...existing portfolio of compounds and,the company wi...nd,opportunities through Merger & Acquisition acti...
(Date:7/22/2008)...herapeutics Development Initiative bring MJFF,s,cu...eadline January 20,2009, NEW YORK, July 22 /PRNe...eed delivery of transformative treatments and a cu...ndation for Parkinson,s Research has awarded,$2.7 ...teams. The awards,were granted under MJFF,s Therap...
(Date:7/22/2008)...tudy Confirms Tyrima Exhibits Excellent Drug-Like ...Results Support Initiation of Phase II Clinical Tr...Newswire/ -- CeNeRx BioPharma,Inc., a clinical st...ive,treatments for diseases of the central nervous... candidate Tyrima(TM) into Phase II trials for the...
(Date:7/22/2008)...Calif., July 22 /- Hyperion,Therapeut...tient enrollment,in its Phase 1/2 clinical trial t...avenging effects of HPN-100 (formally called GT4P)...ients with urea cycle disorders,(UCD). The company...quarter,of this year., (Logo: http://www.newscom...
Breaking Medicine Technology:Progen Terminates PATHWAY Trial & Confirms Focus on Potential High Value Molecules and M&A 2Progen Terminates PATHWAY Trial & Confirms Focus on Potential High Value Molecules and M&A 3Michael J. Fox Foundation Awards $2.7 Million for Industry Efforts to Speed New Parkinson's Therapeutics 2Michael J. Fox Foundation Awards $2.7 Million for Industry Efforts to Speed New Parkinson's Therapeutics 3CeNeRx BioPharma Finalizes Plans to Initiate Phase II Trials for Its Novel Antidepressant Agent Tyrima(TM) Using Innovative Brain Imaging Study 2CeNeRx BioPharma Finalizes Plans to Initiate Phase II Trials for Its Novel Antidepressant Agent Tyrima(TM) Using Innovative Brain Imaging Study 3CeNeRx BioPharma Finalizes Plans to Initiate Phase II Trials for Its Novel Antidepressant Agent Tyrima(TM) Using Innovative Brain Imaging Study 4Hyperion Therapeutics Completes Enrollment in Phase 1/2 Clinical Trial in Patients With Urea Cycle Disorders 2Hyperion Therapeutics Completes Enrollment in Phase 1/2 Clinical Trial in Patients With Urea Cycle Disorders 3Many African Americans have a gene that prolongs life after heart failure 2966 1Many African Americans have a gene that prolongs life after heart failure 2966 2Many African Americans have a gene that prolongs life after heart failure 2966 3Many African Americans have a gene that prolongs life after heart failure 2966 4Allergies Can Dig Into Gardenings Fun 17255 1Allergies Can Dig Into Gardenings Fun 17255 2BIOTECON Diagnostics and MERCK KGaA start worldwide marketing alliance 4712 1BIOTECON Diagnostics and MERCK KGaA start worldwide marketing alliance 4712 2BIOTECON Diagnostics and MERCK KGaA start worldwide marketing alliance 4712 3Angiotechs Corporate Partner Boston Scientific Reports Canadian Approval for TAXUS 28R 29 Liberte 28R 29 Stent System 4710 1Angiotechs Corporate Partner Boston Scientific Reports Canadian Approval for TAXUS 28R 29 Liberte 28R 29 Stent System 4710 2Angiotechs Corporate Partner Boston Scientific Reports Canadian Approval for TAXUS 28R 29 Liberte 28R 29 Stent System 4710 3Angiotechs Corporate Partner Boston Scientific Reports Canadian Approval for TAXUS 28R 29 Liberte 28R 29 Stent System 4710 4
...BRIDGE, Mass.--(BUSINESS WIRE)--Apr 12, 2007 - AVE...ny focused on the,discovery and development of nov...t it will present a total of 12 oral and poster,pr... Research,(AACR) Annual Meeting on April 14-18, 20...ted to share with the cancer community the,pioneer...
...NDON, April 12, 2007--The costs of eradicating,pol...while high in,the short term, are much lower than ...s without eradication. And a recently developed,mo...ive against,type 1 poliomyelitis than an existing ...rticles published Online and in an upcoming,issue ...
Other Medicine Technology:AVEO Pharmaceuticals Novel Oncology Research Platform and Clinical,Pipeline to Be Featured at AACR 2AVEO Pharmaceuticals Novel Oncology Research Platform and Clinical,Pipeline to Be Featured at AACR 3Costs of Eradicating Poliomyelitis Now Are Much Lower Than Trying,to Control It Later 2Costs of Eradicating Poliomyelitis Now Are Much Lower Than Trying,to Control It Later 3
Stainless Steel
2 Sided Pivoted Closed Ring Design,Pointed And Smooth Sides; in stainless steel.
The e.cam single-detector system offers general purpose scanning flexibility with unrestricted access for gurneys and wheelchairs. This cost-effective system features a clinically versatile open gant
In Stainless steel. Available in 1.5, 2.0,3.0 & 3.5 MM
Medicine Products: